Despite its promise, CRISPR technology faces several challenges in the context of neonatal disorders:
Off-Target Effects: CRISPR can sometimes edit unintended parts of the genome, leading to unexpected consequences. Delivery Methods: Efficiently delivering the CRISPR components to specific cells or tissues in newborns remains a significant hurdle. Ethical Concerns: The use of gene-editing technologies raises ethical questions, particularly when it comes to editing the human germline.
